UPDATED Oct 01, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
524689 | ₹3.39 | 0% | -33.7% | ₹101.1m | n/a | n/a | n/a | n/a | ||
PLTT | US$0.0001 | 0% | n/a | US$1.2k | n/a | n/a | n/a | n/a | ||
EEP | €0.34 | 0% | -29.2% | €3.7m | n/a | PB0.6x | n/a | n/a | ||
MESC | CA$0.01 | 0% | -75.0% | CA$858.6k | n/a | PB0.6x | n/a | n/a | ||
CNLK | US$0.0002 | 0% | n/a | US$0 | n/a | n/a | n/a | n/a | ||
RTI.H | CA$0.005 | 0% | n/a | CA$2.7m | n/a | n/a | n/a | n/a | ||
PEXA B | SEK 0.23 | -1.7% | -40.4% | SEK 13.4m | n/a | PS24.3x | n/a | n/a | ||
TBET | US$0.000001 | 0% | n/a | US$14.0 | n/a | n/a | n/a | n/a | ||
VSBC | US$1.00 | 0% | n/a | US$207.0m | n/a | n/a | n/a | n/a | ||
SCD | RON 4.52 | 0% | 55.9% | RON 3.2b | n/a | PE11.6x | n/a | 0% | ||
VOQP | US$0.000001 | 0% | n/a | US$6.0 | n/a | n/a | n/a | n/a | ||
LOWL | CA$0.015 | 0% | -57.1% | CA$272.2k | n/a | PB0.05x | n/a | n/a | ||
RZON.F | US$0.16 | 0% | n/a | US$12.1m | n/a | PB12.2x | n/a | n/a | ||
CHGX | CA$0.005 | 0% | -75.0% | CA$415.6k | n/a | PE-0.3x | n/a | n/a | ||
TNPH | US$0.0024 | 0% | n/a | US$196.1k | n/a | n/a | n/a | n/a | ||
CNFH.F | US$0.000001 | 0% | n/a | US$218.0 | n/a | n/a | n/a | n/a | ||
XBRA | CA$0.005 | 0% | -87.5% | CA$420.7k | n/a | n/a | n/a | n/a | ||
OVIT | US$0.0001 | 0% | n/a | US$2.4k | n/a | n/a | n/a | n/a | ||
ADVT | US$0.000001 | 0% | 0% | US$878.0 | n/a | n/a | n/a | n/a | ||
CBIA | US$0.000001 | 0% | -99.0% | US$4.6k | n/a | n/a | n/a | n/a | ||
YOUR.F | US$0.000001 | 0% | 0% | US$272.0 | n/a | n/a | n/a | n/a | ||
BIOA.F | US$0.0002 | 0% | 19,900.0% | US$15.9k | n/a | n/a | n/a | n/a | ||
NNLX | US$0.0001 | 0% | n/a | US$16.3k | n/a | n/a | n/a | n/a | ||
ZDZT | US$1.92 | 0% | -52.0% | US$84.1k | n/a | n/a | n/a | n/a |